Valuation: Divi's Laboratories Limited

Market Cap 1,946B 20.2B 17.71B 16.41B 15.1B 28.48B 28.82B 196B 76.64B 954B 75.85B 74.21B 3,293B P/E 2027 *
65.1x
P/E 2028 * 53.2x
Enterprise Value 1,912B 19.86B 17.41B 16.13B 14.84B 27.99B 28.33B 192B 75.32B 937B 74.54B 72.94B 3,236B EV / Sales 2027 *
15.6x
EV / Sales 2028 * 13.1x
Free-Float
48%
Yield 2027 *
0.49%
Yield 2028 * 0.54%
1 day+0.16%
1 week+5.64%
Current month+11.42%
1 month+8.71%
3 months+16.72%
6 months+21.90%
Current year+14.67%
1 week 7,200
Extreme 7200
7,438.5
1 month 6,530.5
Extreme 6530.5
7,438.5
Current year 5,647.5
Extreme 5647.5
7,438.5
1 year 5,636.5
Extreme 5636.5
7,438.5
3 years 3,295.3
Extreme 3295.3
7,438.5
5 years 2,730
Extreme 2730
7,438.5
10 years 532.65
Extreme 532.65
7,438.5
Manager TitleAgeSince
Chief Executive Officer 75 25/11/2009
Chief Executive Officer 48 03/01/2020
Director of Finance/CFO 65 31/07/2025
Director TitleAgeSince
Director/Board Member 48 25/11/2009
Chairman 75 25/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+5.64%+8.89%+99.92% 20.15B
+1.16%+0.61%+52.14%+150.98% 1,023B
+0.23%-1.42%+52.25%+47.04% 599B
+0.81%+4.61%+38.53%+78.15% 448B
+0.63%+2.08%+30.59%+21.56% 326B
+1.98%+2.55%+37.13%+37.55% 278B
+0.90%+1.04%+22.09%+15.99% 258B
-1.20%+1.36%-21.14%-41.57% 222B
+0.02%+2.63%+23.23%+55.27% 197B
-2.61%-0.28%+19.75%+60.80% 165B
Average +0.13%+0.20%+26.35%+52.57% 353.52B
Weighted average by Cap. +0.48%-1.15%+37.12%+71.53%

Financials

2027 *2028 *
Net sales 123B 1.27B 1.11B 1.03B 951M 1.79B 1.81B 12.33B 4.82B 60.04B 4.77B 4.67B 207B 145B 1.51B 1.32B 1.22B 1.13B 2.12B 2.15B 14.59B 5.71B 71.05B 5.65B 5.53B 245B
Net income 30.25B 314M 275M 255M 235M 443M 448M 3.04B 1.19B 14.82B 1.18B 1.15B 51.18B 37.04B 385M 337M 312M 287M 542M 549M 3.73B 1.46B 18.15B 1.44B 1.41B 62.68B
Net Debt -33.46B -347M -305M -282M -260M -490M -496M -3.37B -1.32B -16.4B -1.3B -1.28B -56.62B -41.92B -435M -382M -354M -325M -614M -621M -4.22B -1.65B -20.55B -1.63B -1.6B -70.94B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
21/07/26 7,330.00 +0.16% 179,558
20/07/26 ₹7,318.00 +0.97% 434,480
17/07/26 ₹7,247.50 -0.94% 455,060
16/07/26 ₹7,316.00 +0.59% 668,484
15/07/26 ₹7,273.00 +1.18% 726,479
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
7,330.00INR
Average target price
7,088.80INR
Spread / Average Target
-3.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock